Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Sales | 1,414 | 0 | 0 | 0 | 0 |
| Cost of Goods | 1,356 | N/A | N/A | N/A | N/A |
| Gross Profit | 57 | N/A | N/A | N/A | N/A |
| Operating Expenses | 67,475 | 71,703 | 53,126 | 63,071 | 51,727 |
| Operating Income | -67,062 | -71,703 | -53,126 | -63,071 | -51,727 |
| Interest Expense | 283 | 3,157 | 2,531 | 1,488 | 936 |
| Other Income | 3,368 | -504 | -3,322 | -1,491 | -499 |
| Pre-tax Income | -63,977 | -75,364 | -58,980 | -66,050 | -53,161 |
| Income Tax | -1,552 | 3 | 3 | 3 | 2 |
| Net Income Continuous | -62,425 | -75,367 | -58,983 | -66,052 | -53,163 |
| Net Income | $-62,425 | $-75,367 | $-58,983 | $-66,052 | $-53,163 |
| EPS Basic Total Ops | -1.79 | -4.06 | -4.72 | -6.20 | -7.00 |
| EPS Basic Continuous Ops | -1.79 | -4.06 | -4.72 | -6.23 | -6.96 |
| EPS Diluted Total Ops | -1.79 | -4.06 | -4.72 | -6.20 | -7.00 |
| EPS Diluted Continuous Ops | -1.79 | -4.06 | -4.72 | -6.23 | -6.96 |
| EPS Diluted Before Non-Recurring Items | -2.85 | -3.99 | -4.80 | N/A | -7.00 |
| EBITDA(a) | $-66,945 | $-71,589 | $-53,082 | $-62,866 | $-51,465 |